Legend Biotech Corporation (LEGN)

Legend Biotech Corporation (LEGN) is a healthcare company (biotechnology) based in the United States. The share price is $16.27, up 1.75% on the day, which values the company at $3.16B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$16.27+1.75% today
Market value
$3.16B
Forward P/E
30.8×
Funk Score
51/100
Against its own history
Well below its usual priceusual price $84.38
200-week average
$42.1361% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Legend Biotech Corporation in more detail

LEGN trades at 30.8× next year's expected earnings, 2.3× sales. Measured against its own history, the price is 81% below what its usual multiples would imply ($84.38) — well below its usual price. It sits 61% below its 200-week average of $42.13.

Its Funk Score is 51 out of 100 (financial strength 3.4, profitability 2.0, growth 10.0, value 5.0, each out of 10).

In its favour: Operating margin is expanding; More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold LEGN, including Zhang Lei (20.8% of the portfolio).

Superinvestors holding LEGN

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:LEGN vs DFTX (Legend Biotech Corporation vs Definium Therapeutics)LEGN vs OPCH (Legend Biotech Corporation vs Option Care Health)LEGN vs TVTX (Legend Biotech Corporation vs Travere Therapeutics)LEGN vs CRSP (Legend Biotech Corporation vs CRISPR Therapeutics)LEGN vs HTFL (Legend Biotech Corporation vs Heartflow)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Legend Biotech Corporation (LEGN): questions and answers

What is Legend Biotech Corporation's market cap?

Legend Biotech Corporation is valued at $3.16B at a share price of $16.27.

Is LEGN overvalued or undervalued?

Against its own history, LEGN is well below its usual price: the price is 81% below the $84.38 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is LEGN above its 200-week moving average?

No. LEGN is 61.4% below its 200-week average of $42.13. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Legend Biotech Corporation growing?

Over the last three fiscal years Legend Biotech Corporation's revenue grew 106.4% a year.

Does LEGN pay a dividend?

Legend Biotech Corporation does not currently pay a regular dividend.

Which famous investors own LEGN?

In their latest quarterly filings, Zhang Lei (20.8% of the portfolio) hold LEGN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Legend Biotech Corporation (LEGN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LEGN

Underlying data: Yahoo Finance; company filings with the SEC.